People · Operator
Named in public records as an officer, director or promoter · active 2020–2022 · Investment Vehicle, Healthtech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| FCA Venture Partners VII QP, LP | — | Investment Vehicle | Series C | $60.3M | $847.5M | 2021 |
| FCA Health Innovations II QP, LP | — | Healthtech | Series C | $55.1M | $1.3B | 2020 |
| FCA Venture Partners VII, LP | — | Investment Vehicle | Series A | $8.8M | $98.2M | 2021 |
| FCA Health Innovations II, LP | — | Healthtech | Series A | $8.5M | $167.8M | 2020 |
| NVOLVE, Inc. | — | Other Health Care | Pre-Seed | $1.3M | $5.0M | 2021 |
James A Patton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James A Patton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.